Supplemental Consolidating Data - Cash Flows (Details) - USD ($) $ in Thousands	3 Months Ended						9 Months Ended
	Sep. 26, 2021	Jun. 27, 2021	Mar. 28, 2021	Sep. 27, 2020	Jun. 28, 2020	Mar. 29, 2020	Sep. 26, 2021	Sep. 27, 2020
Cash flows from operating activities:
Net income	$ 162,973	$ 206,340	$ 259,144	$ 120,218	$ (92,217)	$ 69,695	$ 628,457	$ 97,696
Adjustments to reconcile Net income to Net cash provided by operating activities:
Depreciation and amortization							122,483	140,057
Amortization of deferred loan origination costs							63,265	52,374
Amortization of financing origination fees							10,426	10,628
Provision for long-term employee benefits							19,640	23,557
Employee benefit plan contributions and payments							(14,677)	(5,456)
Stock compensation expense							34,032	12,076
Net change in wholesale finance receivables related to sales							(22,031)	330,793
Provision for credit losses	11,208			7,835			4,935	178,433
Deferred income taxes							10,626	(18,978)
Other, net							2,094	(10,863)
Changes in current assets and liabilities:
Accounts receivable, net							(148,670)	29,630
Finance receivables – accrued interest and other							11,088	5,097
Inventories, net							31,874	273,668
Accounts payable and accrued liabilities							168,306	(16,922)
Other current assets							3,703
Total adjustments							297,094	1,037,372
Net cash provided by operating activities							925,551	1,135,068
Cash flows from investing activities:
Capital expenditures							(61,476)	(92,295)
Origination of finance receivables							(3,444,953)	(2,873,259)
Collections on finance receivables							2,968,397	2,730,166
Other investing activities							2,485	334
Net cash used by investing activities							(535,547)	(235,054)
Cash flows from financing activities:
Repayments of medium-term notes							(1,400,000)	(1,400,000)
Proceeds from securitization debt							1,169,910	2,064,450
Repayments of securitization debt							(1,013,820)	(735,885)
Borrowings of asset-backed commercial paper							27,406	225,187
Repayments of asset-backed commercial paper							(206,671)	(236,846)
Net (decrease) increase in unsecured commercial paper							(261,978)	509,978
Net increase in credit facilities							0	150,000
Net increase in deposits							210,144	29,992
Dividends paid							(69,316)	(65,002)
Repurchase of common stock							(11,545)	(7,895)
Issuance of common stock under share-based plans							4,324	96
Net cash (used) provided by financing activities							(1,551,546)	1,930,677
Effect of exchange rate changes on cash, cash equivalents and restricted cash							(11,050)	6,071
Cash, cash equivalents and restricted cash:
Cash, cash equivalents and restricted cash, beginning of period			3,409,168			$ 905,366	3,409,168	905,366
Net increase (decrease) in cash, cash equivalents and restricted cash							(1,172,592)	2,836,762
Cash, cash equivalents and restricted cash, end of period	2,236,576			$ 3,742,128			2,236,576	$ 3,742,128
HDMC Entities
Cash flows from financing activities:
Proceeds from securitization debt							0
HDFS Entities
Cash flows from financing activities:
Proceeds from securitization debt							1,169,910
Reportable Legal Entities | HDMC Entities
Cash flows from operating activities:
Net income	206,561						629,945
Adjustments to reconcile Net income to Net cash provided by operating activities:
Depreciation and amortization							115,779
Amortization of deferred loan origination costs							0
Amortization of financing origination fees							517
Provision for long-term employee benefits							19,640
Employee benefit plan contributions and payments							(14,677)
Stock compensation expense							31,089
Net change in wholesale finance receivables related to sales							0
Provision for credit losses	0						0
Deferred income taxes							4,710
Other, net							3,320
Changes in current assets and liabilities:
Accounts receivable, net							(379,821)
Finance receivables – accrued interest and other							0
Inventories, net							31,874
Accounts payable and accrued liabilities							162,088
Other current assets							(11,127)
Total adjustments							(36,608)
Net cash provided by operating activities							593,337
Cash flows from investing activities:
Capital expenditures							(59,128)
Origination of finance receivables							0
Collections on finance receivables							0
Net cash used by investing activities							(56,643)
Cash flows from financing activities:
Repayments of medium-term notes							0
Repayments of securitization debt							0
Borrowings of asset-backed commercial paper							0
Repayments of asset-backed commercial paper							0
Net (decrease) increase in unsecured commercial paper							0
Net increase in deposits							0
Dividends paid							(69,316)
Repurchase of common stock							(11,545)
Issuance of common stock under share-based plans							4,324
Net cash (used) provided by financing activities							(76,537)
Effect of exchange rate changes on cash, cash equivalents and restricted cash							(11,304)
Cash, cash equivalents and restricted cash:
Cash, cash equivalents and restricted cash, beginning of period			666,161				666,161
Net increase (decrease) in cash, cash equivalents and restricted cash							448,853
Cash, cash equivalents and restricted cash, end of period	1,115,014						1,115,014
Reportable Legal Entities | HDFS Entities
Cash flows from operating activities:
Net income	76,210						238,684
Adjustments to reconcile Net income to Net cash provided by operating activities:
Depreciation and amortization							6,704
Amortization of deferred loan origination costs							63,265
Amortization of financing origination fees							9,909
Provision for long-term employee benefits							0
Employee benefit plan contributions and payments							0
Stock compensation expense							2,943
Net change in wholesale finance receivables related to sales							0
Provision for credit losses	11,208						4,935
Deferred income taxes							6,028
Other, net							(1,397)
Changes in current assets and liabilities:
Accounts receivable, net							0
Finance receivables – accrued interest and other							11,088
Inventories, net							0
Accounts payable and accrued liabilities							247,740
Other current assets							3,952
Total adjustments							355,167
Net cash provided by operating activities							593,851
Cash flows from investing activities:
Capital expenditures							(2,348)
Origination of finance receivables							(6,157,658)
Collections on finance receivables							5,659,465
Other investing activities							0
Net cash used by investing activities							(500,541)
Cash flows from financing activities:
Repayments of medium-term notes							(1,400,000)
Repayments of securitization debt							(1,013,820)
Borrowings of asset-backed commercial paper							27,406
Repayments of asset-backed commercial paper							(206,671)
Net (decrease) increase in unsecured commercial paper							(261,978)
Net increase in deposits							210,144
Dividends paid							(240,000)
Repurchase of common stock							0
Issuance of common stock under share-based plans							0
Net cash (used) provided by financing activities							(1,715,009)
Effect of exchange rate changes on cash, cash equivalents and restricted cash							254
Cash, cash equivalents and restricted cash:
Cash, cash equivalents and restricted cash, beginning of period			2,743,007				2,743,007
Net increase (decrease) in cash, cash equivalents and restricted cash							(1,621,445)
Cash, cash equivalents and restricted cash, end of period	1,121,562						1,121,562
Consolidating Adjustments
Cash flows from operating activities:
Net income	(119,798)						(240,172)
Adjustments to reconcile Net income to Net cash provided by operating activities:
Depreciation and amortization							0
Amortization of deferred loan origination costs							0
Amortization of financing origination fees							0
Provision for long-term employee benefits							0
Employee benefit plan contributions and payments							0
Stock compensation expense							0
Net change in wholesale finance receivables related to sales							(22,031)
Provision for credit losses	0						0
Deferred income taxes							(112)
Other, net							171
Changes in current assets and liabilities:
Accounts receivable, net							231,151
Finance receivables – accrued interest and other							0
Inventories, net							0
Accounts payable and accrued liabilities							(241,522)
Other current assets							10,878
Total adjustments							(21,465)
Net cash provided by operating activities							(261,637)
Cash flows from investing activities:
Capital expenditures							0
Origination of finance receivables							2,712,705
Collections on finance receivables							(2,691,068)
Other investing activities							0
Net cash used by investing activities							21,637
Cash flows from financing activities:
Repayments of medium-term notes							0
Proceeds from securitization debt							0
Repayments of securitization debt							0
Borrowings of asset-backed commercial paper							0
Repayments of asset-backed commercial paper							0
Net (decrease) increase in unsecured commercial paper							0
Net increase in deposits							0
Dividends paid							240,000
Repurchase of common stock							0
Issuance of common stock under share-based plans							0
Net cash (used) provided by financing activities							240,000
Effect of exchange rate changes on cash, cash equivalents and restricted cash							0
Cash, cash equivalents and restricted cash:
Cash, cash equivalents and restricted cash, beginning of period			$ 0				0
Net increase (decrease) in cash, cash equivalents and restricted cash							0
Cash, cash equivalents and restricted cash, end of period	$ 0						$ 0